Navigation Links
Warner Chilcott Announces Earnings Release Date and Conference Call for First Quarter 2008 Financial Results
Date:4/22/2008

ST. DAVID'S, Bermuda, April 22 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will issue its first quarter 2008 financial results prior to the market opening on Friday, May 9, 2008.

In addition to issuing a press release, the Company will host a conference call for all interested parties on Friday, May 9, 2008 at 8:00 AM (Eastern Time) to review the results. To participate in the call, please dial (877) 397-0297 in the United States and Canada or (719) 325-4913 internationally.

Investors and other interested parties may also access the conference call via a simultaneous audio webcast by visiting http://ir.wcrx.com and clicking on Events & Presentations.

A replay of the conference call will be available for two weeks following the call and can be accessed by dialing (888) 203-1112 within the United States and Canada or (719) 457-0820 internationally. The passcode for the replay is 6773545.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare and dermatology segments of the U.S. pharmaceuticals market. It is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-F


'/>"/>
SOURCE Warner Chilcott Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Mark Whitacre, Ph.D. Promoted at Cypress Systems, Inc. and a Warner Brothers Movie to Be Filmed About Him
2. Warner Chilcott Reports the Death of Its Director James Andress
3. Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007
4. Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results
5. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
6. Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2007 Financial Results
7. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
8. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
9. Webcast Alert: Transgenomic Inc. Announces First Quarter 2008 Earnings Release Conference Call Webcast
10. Rochester Medical Announces Second Quarter 2008 Earnings Conference Call April 29, 2008
11. BioMed Realty Trust Announces Exercise of Over-Allotment Option for Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... A recent study from researchers in ... find that those who took probiotics were able to run ... study showed that in extreme heat conditions, probiotics were able ... acne treatment explains what this new discovery means ... their skin condition. , While researchers tote the benefits ...
(Date:5/21/2013)... 2013 First patients dosed with ... bromide designed using Prosonix, particle engineering platform ... of inhaled Respiratory Medicines by Design , has ... will assess its effect on lung function and the ... moderate to severe chronic obstructive pulmonary disease (COPD). The ...
(Date:5/21/2013)... Custom Learning Designs, Inc.(CLD) unveils the ... Tin Can API combined with its own proprietary ... leading developer of training content and solutions for ... , Tin Can API is a cost-effective learning ... more accurately measure the Return on Education (ROE) ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Alpha ... distributor , will be exhibiting for the 13th ... of Medical Instrumentation (AAMI) 2013 Conference and Expo. ... support, distribute, and manufacture healthcare technologies. This year’s ... Long Beach, California. , The three-day event ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2
... 2011 UV Flu Technologies, Inc. ( ... to announce it has expanded its International Distribution by adding ... its relationship with the Company,s Distributor in India, Ormed Systems, ... as well as other parts of the world. The Company ...
... Avaxia Biologics, Inc. , a privately-held biotech ... the gastrointestinal tract, announced today that the company completed ... A angel-led financing. Cherrystone Angels of Providence, Rhode Island ... and other undisclosed individuals. Mr. Robert Manning, the co-Chairman ...
... SQNM ), a life sciences company providing innovative ... Lazard Capital Markets 8th Annual Healthcare Conference at the Pierre ... Harry F. Hixson, Jr, Ph.D., Chairman and CEO, and Ronald ... will present on Tuesday, November 15, 2011 beginning at 8:30 ...
Cached Biology Technology:UV Flu Technologies Expands Its International Footprint 2UV Flu Technologies Expands Its International Footprint 3Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease 2Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference 2
(Date:5/22/2013)... Researchers working to improve durability in fuel cell ... University, have discovered links between electrode degradation processes ... quantifying the effects of electrode degradation stressors in ... membrane lifetime. , The findings of the study, ... the latest in a long-term study at Burnaby-based ...
(Date:5/22/2013)... drastically reduces the time and effort needed to ... biotechnology, scientists are reporting. Published in the journal ... the way for more rapid development of designer ... activities. , Keith Shearwin and colleagues explain that ... material DNA into a bacterium,s genome is critical ...
(Date:5/22/2013)... on how climate change will affect interactions between species ... Journal of Animal Ecology . This knowledge, they say, ... of how species are likely to be impacted by ... recognition among biologists that climate change is affecting how ... going to have very important consequences for the stability ...
Breaking Biology News(10 mins):Tests lead to doubling of fuel cell life 2UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5
... Carolina State University have found a specific gene in corn that ... diseases. In a paper ... Sciences , NC State plant pathologists and crop scientists pinpoint ... to Southern leaf blight, gray leaf spot and Northern leaf blight, ...
... use of biotechnology increases and more companies move ... to begin full-scale commercialization of seed mixtures in ... will become even more difficult. "Seed mixtures ... of larval behavior and greater adoption of insecticidal ...
... has for the first time found that female-to-male transsexual ... traits. , The Medical Research Council (MRC) funded ... and Developmental Disorders , has important implications for the ... persists into adulthood, and for the ,extreme male brain, ...
Cached Biology News:Study shows corn gene provides resistance to multiple diseases 2Seed mixtures and insurance pest management: Future norm in the Corn Belt? 2Female-to-male transsexual people have more autistic traits 2
... Error-free cloning of BAC (100+kb), fosmid ... Greater insert stability than any othe BAC ... for high yields and easy recombinant DNA ... or transcription-free (pSMART VC) vectors for the ...
Trop-2 Purified Anti-Human clone 162-46, Isotype Mouse IgG 1 , 100 µg Consult technical datasheet for details....
... BAC (100+kb), fosmid (40kb), and large plasmid ... any othe BAC vector. On command 20-50 ... easy recombinant DNA purification. Available with blue-white ... vectors for the highest insert stability. Kits ...
... Adapted to Sf-900 II ... isolated from Spodoptera frugiperda ... cells (1). The Sf21 ... serum-free suspension culture in ...
Biology Products: